AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
在奥本海默将股票从表现上调至跑赢大盘并宣布12美元的目标股价之后，AngioDynamics的股价走高。
AngioDynamics Shares Are Trading Higher After Oppenheimer Upgraded the Stock From Perform to Outperform and Announced a $12 Price Target.
在奥本海默将股票从表现上调至跑赢大盘并宣布12美元的目标股价之后，AngioDynamics的股价走高。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。